• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗生素的发展以及海洋微生物对抗生素耐药性浪潮的遏制前景。

Development of antibiotics and the future of marine microorganisms to stem the tide of antibiotic resistance.

作者信息

Kasanah Noer, Hamann Mark T

机构信息

Department of Pharmacognosy, National Center for Natural Product Research, School of Pharmacy, The University of Mississippi, MS 38677, USA.

出版信息

Curr Opin Investig Drugs. 2004 Aug;5(8):827-37.

PMID:15600239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4969015/
Abstract

Antibiotics remain essential tools in the control of infectious diseases. With the emergence of new diseases, resistant forms of diseases such as tuberculosis and malaria, as well as the emergence of multidrug-resistant bacteria, it has become essential to develop novel antibiotics. Development of the existing antibiotics involved three strategies, including discovery of new target sites, modification of existing antibiotic structures, and the identification of new resources for novel antibiotics. Marine microorganisms have clearly become an essential new resource in the discovery of new antibiotic leads.

摘要

抗生素仍然是控制传染病的重要工具。随着新疾病的出现、结核病和疟疾等耐药性疾病形式的出现以及多重耐药细菌的出现,开发新型抗生素变得至关重要。现有抗生素的开发涉及三种策略,包括发现新的靶点、修饰现有抗生素结构以及鉴定新型抗生素的新资源。海洋微生物显然已成为发现新抗生素先导物的重要新资源。

相似文献

1
Development of antibiotics and the future of marine microorganisms to stem the tide of antibiotic resistance.抗生素的发展以及海洋微生物对抗生素耐药性浪潮的遏制前景。
Curr Opin Investig Drugs. 2004 Aug;5(8):827-37.
2
Marine bacteria and fungi as promising source for new antibiotics.海洋细菌和真菌是新型抗生素的有前途的来源。
Drug Dev Res. 2019 Feb;80(1):24-27. doi: 10.1002/ddr.21482. Epub 2018 Oct 28.
3
Economics of antibiotic resistance.抗生素耐药性经济学
Expert Rev Anti Infect Ther. 2008 Aug;6(4):523-39. doi: 10.1586/14787210.6.4.523.
4
Bacterial resistance mechanism: what proteomics can elucidate.细菌耐药机制:蛋白质组学可以阐明的内容。
FASEB J. 2013 Apr;27(4):1291-303. doi: 10.1096/fj.12-221127. Epub 2013 Jan 24.
5
Marine bacteria: potential sources for compounds to overcome antibiotic resistance.海洋细菌:克服抗生素耐药性的潜在化合物来源。
Appl Microbiol Biotechnol. 2013 Jun;97(11):4763-73. doi: 10.1007/s00253-013-4905-y. Epub 2013 May 3.
6
Exploiting current understanding of antibiotic action for discovery of new drugs.利用当前对抗生素作用的认识来发现新药。
Symp Ser Soc Appl Microbiol. 2002(31):4S-15S.
7
Detection of antibiotic resistant bacteria inhabiting the sand of non-recreational marine beach.检测非休闲性海滨沙滩沙中栖息的抗生素耐药菌。
Mar Pollut Bull. 2010 Feb;60(2):207-14. doi: 10.1016/j.marpolbul.2009.09.025. Epub 2009 Oct 28.
8
[On the importance of multidrug-resistant strains of pathogenic microorganisms in ophthalmic practice].
Vestn Oftalmol. 2015 Mar-Apr;131(2):110-114. doi: 10.17116/oftalma20151312110-114.
9
Toward computer-made artificial antibiotics.朝着计算机制造的人工抗生素迈进。
Curr Opin Microbiol. 2019 Oct;51:30-38. doi: 10.1016/j.mib.2019.03.004. Epub 2019 May 11.
10
Antibiotics from Deep-Sea Microorganisms: Current Discoveries and Perspectives.深海微生物来源的抗生素:最新发现与展望。
Mar Drugs. 2018 Sep 29;16(10):355. doi: 10.3390/md16100355.

引用本文的文献

1
Isolation of Ten New Sesquiterpenes and New Abietane-Type Diterpenoid with Immunosuppressive Activity from Marine Fungus sp.从海洋真菌sp.中分离出十种具有免疫抑制活性的新倍半萜和新枞酸型二萜类化合物
Pharmaceuticals (Basel). 2025 May 16;18(5):737. doi: 10.3390/ph18050737.
2
New marine-derived indolymethyl pyrazinoquinazoline alkaloids with promising antimicrobial profiles.具有良好抗菌特性的新型海洋来源吲哚甲基吡嗪喹唑啉生物碱。
RSC Adv. 2020 Aug 21;10(52):31187-31204. doi: 10.1039/d0ra05319h.
3
Bacterial Natural Product Drug Discovery for New Antibiotics: Strategies for Tackling the Problem of Antibiotic Resistance by Efficient Bioprospecting.用于发现新型抗生素的细菌天然产物药物研发:通过高效生物勘探应对抗生素耐药性问题的策略
Antibiotics (Basel). 2021 Jul 10;10(7):842. doi: 10.3390/antibiotics10070842.
4
Marine Microbial-Derived Antibiotics and Biosurfactants as Potential New Agents against Catheter-Associated Urinary Tract Infections.海洋微生物来源的抗生素和生物表面活性剂作为对抗导管相关性尿路感染的潜在新型药物。
Mar Drugs. 2021 Apr 29;19(5):255. doi: 10.3390/md19050255.
5
Novel Targets for Antimicrobials.抗菌药物的新靶点
Turk J Pharm Sci. 2020 Oct;17(5):565-575. doi: 10.4274/tjps.galenos.2020.90197. Epub 2020 Oct 30.
6
Marine Macrolides with Antibacterial and/or Antifungal Activity.具有抗菌和/或抗真菌活性的海洋大环内酯类化合物。
Mar Drugs. 2019 Apr 23;17(4):241. doi: 10.3390/md17040241.
7
Marine Spirotetronates: Biosynthetic Edifices That Inspire Drug Discovery.海洋螺旋四烯酮:激发药物研发灵感的生物合成建筑。
Mar Drugs. 2019 Apr 19;17(4):232. doi: 10.3390/md17040232.
8
Ethyl 3-oxo-2-(2,5-dioxopyrrolidin-3-yl)butanoate Derivatives: Anthelmintic and Cytotoxic Potentials, Antimicrobial, and Docking Studies.3-氧代-2-(2,5-二氧代吡咯烷-3-基)丁酸乙酯衍生物:驱虫和细胞毒性潜力、抗菌及对接研究
Front Chem. 2017 Dec 12;5:119. doi: 10.3389/fchem.2017.00119. eCollection 2017.
9
An analysis of the sponge microbiome yields an actinomycete that produces the natural product manzamine A.对海绵微生物群的分析产生了一种能产生天然产物曼赞胺A的放线菌。
Front Mar Sci. 2014 Oct;1. doi: 10.3389/fmars.2014.00054. Epub 2014 Oct 17.
10
Antibacterials from the sea.海洋来源的抗菌药物。
Chemistry. 2010 Nov 8;16(42):12512-25. doi: 10.1002/chem.201001279.

本文引用的文献

1
Microbial diversity of marine sponges.海洋海绵的微生物多样性。
Prog Mol Subcell Biol. 2003;37:59-88. doi: 10.1007/978-3-642-55519-0_3.
2
Sponge-associated bacteria: general overview and special aspects of bacteria associated with Halichondria panicea.海绵相关细菌:与泛黄海绵相关细菌的概述及特殊方面
Prog Mol Subcell Biol. 2003;37:35-57. doi: 10.1007/978-3-642-55519-0_2.
3
Bioterrorism and biodefence research: changing the focus of microbiology.生物恐怖主义与生物防御研究:改变微生物学的重点
Nat Rev Microbiol. 2003 Oct;1(1):70-4. doi: 10.1038/nrmicro728.
4
Where will new antibiotics come from?新型抗生素将从何而来?
Nat Rev Microbiol. 2003 Oct;1(1):65-70. doi: 10.1038/nrmicro727.
5
Biologically active secondary metabolites from myxobacteria.粘细菌产生的具有生物活性的次生代谢产物。
Biotechnol Adv. 1993;11(2):219-77. doi: 10.1016/0734-9750(93)90042-l.
6
Gone gene fishing: how to catch novel marine antimicrobials.寻找“消失”的基因:如何捕获新型海洋抗菌药物
Trends Biotechnol. 2003 Aug;21(8):362-9. doi: 10.1016/S0167-7799(03)00145-8.
7
Drugs from the deep: marine natural products as drug candidates.来自深海的药物:作为候选药物的海洋天然产物
Drug Discov Today. 2003 Jun 15;8(12):536-44. doi: 10.1016/s1359-6446(03)02713-2.
8
The challenge of multidrug resistance: actual strategies in the development of novel antibacterials.多重耐药性的挑战:新型抗菌药物研发中的实际策略
Appl Microbiol Biotechnol. 2004 Jan;63(4):335-43. doi: 10.1007/s00253-003-1344-1. Epub 2003 Jun 12.
9
Deletion of scbA enhances antibiotic production in Streptomyces lividans.scbA基因的缺失增强了变铅青链霉菌的抗生素产量。
Appl Microbiol Biotechnol. 2003 Jun;61(5-6):512-6. doi: 10.1007/s00253-003-1277-8. Epub 2003 Mar 22.
10
Antimalarial dihydroisocoumarins produced by Geotrichum sp., an endophytic fungus of Crassocephalum crepidioides.由厚喙菊内生真菌地霉属产生的抗疟二氢异香豆素。
J Nat Prod. 2003 May;66(5):709-11. doi: 10.1021/np0205598.